Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 10, 2026 23:26 ET | Source: Alleron Expert Group

Alleron Expert Group Marks Six Years of 100% Client Retention, Announces Expanded Cloud Services Portfolio

BOSTON, MA, April 10, 2026 (GLOBE NEWSWIRE) -- Alleron Expert Group (AEG), a Boston-based cloud consulting and managed services firm, today announced a significant expansion of its service portfolio...
April 10, 2026 11:00 ET | Source: Humber River Hospital

Humber River Health Renames Wilson Site Hennick Humber Hospital Following Transformational $50 Million Gift

TORONTO, April 10, 2026 (GLOBE NEWSWIRE) -- Humber River Health has announced that its Wilson site will be renamed Hennick Humber Hospital in recognition of a transformational $50 million gift from...
April 10, 2026 09:30 ET | Source: Hispanic Information and Telecommunications Network, Inc

HITN Marks World Parkinson's Day with Special Broadcast of The Long Road to Hope: Ending Parkinson’s Disease

HITN airs The Long Road to Hope: Ending Parkinson’s Disease, by U. of Rochester CHeT, on Apr 11 at 5 PM EDT & on-demand via HITNGo.
April 10, 2026 08:55 ET | Source: BizClik Media Limited

Data Centre LIVE 2026 Confirms Strong Industry Demand with Sponsorship Opportunities Closing Soon

Final sponsorship opportunities available for Data Centre LIVE 2026, bringing together global leaders to explore AI, energy, and infrastructure innovation
April 10, 2026 08:15 ET | Source: LifeMD, Inc.

LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that it is now offering Foundayo™ (orforglipron) to...
April 10, 2026 08:00 ET | Source: Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT

MONTREAL and CHARLOTTE, N.C., April 10, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of...
April 07, 2026 04:00 ET | Source: Oculis Holding AG

Oculis to Participate in Upcoming Investor Conferences

ZUG, Switzerland, April 07, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing...